𝛼SK or SearchAequitas: CSPC Innovation Pharma A/H Listing - 1H26’s Performance Boosted by Licensing Deal
94 Views05 Oct 2026 15:36
CSPC Innovation Pharmaceutical-A (300765 CH) CSPC Innovation Pharma aims to raise around US$500m in its H-share listing.
What is covered in the Full Insight:
- Introduction and Background of CSPC
- CSPC's Product Segments and Performance
- Financial Performance and Margin Analysis
- Geographic Revenue Trends
- Conclusion and Future Outlook
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Aequitas: CSPC Innovation Pharma A/H Listing - 1H26’s Performance Boosted by Licensing Deal05 Oct 2026
x